Trial Profile
Haemocomplettan® P in Patients Experiencing Acute Bleeding While Undergoing Aortic Replacement Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2014
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors CSL Behring
- 17 Oct 2014 New trial record